Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 222

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia

Gelsi‐Boyer, Véronique, Trouplin, Virginie, Roquain, Julien, Adélaïde, José, Carbuccia, Nadine, Esterni, Benjamin, Finetti, Pascal, Murati, Anne, Arnoulet, Christine, Zerazhi, Hacène, Fezoui, Hacène, Tadrist, Zoulika, Nezri, Meyer, Chaffanet, Max, Mozziconacci, Marie‐Joëlle, Vey, Norbert, Birnbaum, Daniel · 2010 · British Journal of Haematology

Abstract

Summary: Chronic myelomonocytic leukaemia (CMML) is a haematological disease currently classified in the category of myelodysplastic syndromes/myeloproliferative neoplasm (MDS/MPN) because of its dual clinical and biological presentation. The molecular biology of CMML is poorly characterized. We studied a series of 53 CMML samples including 31 cases of myeloproliferative form (MP‐CMML) and 22 cases of myelodysplastic forms (MD‐CMML) using array‐comparative genomic hybridisation (aCGH) and sequencing of 13 candidate genes including ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, PTPN11, RUNX1, TET2 and WT1. Mutations in ASXL1 and in the genes associated with proliferation (CBL, FLT3, PTPN11, NRAS) were mainly found in MP‐CMML cases. Mutations of ASXL1 correlated with an evolution toward an acutely transformed state: all CMMLs that progressed to acute phase were mutated and none of the unmutated patients had evolved to acute leukaemia. The overall survival of ASXL1 mutated patients was lower than that of unmutated patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2141.2010.08381.x

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 222

Metadata

Authors
Gelsi‐Boyer, V., Trouplin, V., Roquain, J., Adélaïde, J., Carbuccia, N., Esterni, B., Finetti, P., Murati, A., Arnoulet, C., Zerazhi, H., Fezoui, H., Tadrist, Z., Nezri, M., Chaffanet, M., Mozziconacci, M., Vey, N., & Birnbaum, D.
Venue
British Journal of Haematology
Publisher
Wiley
Published
2010-09-29
Volume
151
Issue
4
Pages
365-375
ISSN
  • 0007-1048 (ISSN-L)
  • 1365-2141
OpenAlex
W1498250169
Cited by
222
References
1
FWCI
13.29
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia. https://app.cochat.ai/papers/10.1111/j.1365-2141.2010.08381.x
The paper
Gelsi‐Boyer, V., Trouplin, V., Roquain, J., Adélaïde, J., Carbuccia, N., Esterni, B., Finetti, P., Murati, A., Arnoulet, C., Zerazhi, H., Fezoui, H., Tadrist, Z., Nezri, M., Chaffanet, M., Mozziconacci, M., Vey, N., & Birnbaum, D. (2010). ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia. British Journal of Haematology. https://doi.org/10.1111/j.1365-2141.2010.08381.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.